XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Class A Common Shares
Class B Common Shares
Common stock
Class A Common Shares
Common stock
Class B Common Shares
Additional paid-in capital
Retained deficit
Treasury stock
Beginning balance (in shares) at Apr. 30, 2021       35,629,566 1,821,587      
Beginning balance at Apr. 30, 2021 $ 122,391     $ 3,563 $ 182 $ 159,492 $ (15,287) $ (25,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Proceeds from stock options exercised (in shares) 545,242     545,242        
Proceeds from stock options exercised $ 5,714     $ 54   5,660    
Stock-based compensation 1,817         1,817    
Net earnings 6,261           6,261  
Dividends declared [1] (7,336)           (7,336)  
Ending balance (in shares) at Oct. 31, 2021       36,174,808 1,821,587      
Ending balance at Oct. 31, 2021 128,847     $ 3,617 $ 182 166,969 (16,362) (25,559)
Beginning balance (in shares) at Jul. 31, 2021       36,028,566 1,821,587      
Beginning balance at Jul. 31, 2021 126,534     $ 3,603 $ 182 164,299 (15,991) (25,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Proceeds from stock options exercised (in shares)       146,242        
Proceeds from stock options exercised 1,642     $ 14   1,628    
Stock-based compensation 1,042         1,042    
Net earnings 3,314           3,314  
Dividends declared [2] (3,685)           (3,685)  
Ending balance (in shares) at Oct. 31, 2021       36,174,808 1,821,587      
Ending balance at Oct. 31, 2021 128,847     $ 3,617 $ 182 166,969 (16,362) (25,559)
Beginning balance (in shares) at Apr. 30, 2022   36,405,695 1,821,587 36,405,695 1,821,587      
Beginning balance at Apr. 30, 2022 $ 132,976     $ 3,641 $ 182 171,948 (17,236) (25,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Proceeds from stock options exercised (in shares) 97,800     97,800        
Proceeds from stock options exercised $ 1,145     $ 9   1,136    
Stock-based compensation 2,649         2,649    
Net earnings 4,214           4,214  
Dividends declared [1] (7,416)           (7,416)  
Ending balance (in shares) at Oct. 31, 2022   36,503,495 1,821,587 36,503,495 1,821,587      
Ending balance at Oct. 31, 2022 133,568     $ 3,650 $ 182 175,733 (20,438) (25,559)
Beginning balance (in shares) at Jul. 31, 2022       36,448,695 1,821,587      
Beginning balance at Jul. 31, 2022 133,181     $ 3,645 $ 182 173,721 (18,808) (25,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Proceeds from stock options exercised (in shares) [2]       54,800        
Proceeds from stock options exercised [2] 674     $ 5   669    
Stock-based compensation 1,343         1,343    
Net earnings 2,081           2,081  
Dividends declared (3,711)           (3,711)  
Ending balance (in shares) at Oct. 31, 2022   36,503,495 1,821,587 36,503,495 1,821,587      
Ending balance at Oct. 31, 2022 $ 133,568     $ 3,650 $ 182 $ 175,733 $ (20,438) $ (25,559)
[1] Amounts adjusted for rounding
[2] Amounts adjusted for rounding